Senior insider sale
EVP, Research & Development at NOVAVAX INC — senior position signals high conviction
$531.5K
51.38K shares
What this filing means
DRAGHIA-AKLI RUXANDRA plans to sell 51.38K shares of NOVAVAX INC valued at approximately $531.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2026ACC: 0001628280-26-038512
Officer· EVP, Research & Development
Since Mar 2026
51.38K
Shares to sell
$531.5K
Approx. market value
21.38K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Plan Activity
n/a
5/27/2026
21.38KTotal acquired21.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/27/2026 | Stock Plan Activity n/a | 21.38K | — |
| Total | 21.38K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
30K
Market value
$296.1K
5/7/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.38K
Market value
$235.4K
5/27/2026
Total
Units
51.38K
Value
$531.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/7/2026 | 30K | $296.1K | — | Completed |
| Planned — Approximate Date | ||||
5/27/2026 | 21.38K | $235.4K | NASDAQ | Planned |
| Total | 51.38K | $531.5K | ||